Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Tarbabyon Apr 27, 2024 11:10pm
263 Views
Post# 36011342

RE:17681 Article views with this one ! Institution access ?

RE:17681 Article views with this one ! Institution access ?PDT depends on  photons triggering a photo reactive compound to create reactive oxygen which then damages or destroys cancer cells.
But external light photons can not penetrate to reach most deep tumours.
Cherenkov radiation are blue light photons created deep in a body by xrays striking a photo reactive material. These photons then trigger reactive oxygen to damage or destroy the deep tumour same as PDT.
This is my understanding of how xrays can kill deep tumours. 
This can work on any tumour anywhere in the body.
Rutherrin or Rudivar reacts extremely well to the blue light photons wavelength.
This is a sure winner..it just needs time and money to do the lab work and then the trials.
Roger has to find a financial partner with deeper pockets to pull it off...imo.



<< Previous
Bullboard Posts
Next >>